ibuprofen Articles
Australian Judge rules against Merck & Co’s Vioxx, saying the pain drug is not fit for sale
5 March 2010
Pfizer’s Wyeth awarded UK contract to supply Prevenar 13; but drops European OTC ibuprofen/diphenhydramine development
20 January 2010
Double whammy for Johnson & Johnson, as DoJ sues on alleged “kickbacks,” and Tylenol contamination discovered
18 January 2010
Four drugmakers to pay $124 million for submission of false claims to USA’s Medicaid
20 October 2009
Licorice extract blocks CRC growth in mice
30 March 2009
FDA warns over use of topical anesthetics
26 January 2009
PDCO meeting sees good news for J&J but a mix for GSK and AZ; Janssen pulls Invega app
12 January 2009
FTC sues Ovation over PDA monopoly
22 December 2008
NSAIDs reduce breast cancer link 21%
13 October 2008
Paracetamol linked to asthma risk
29 September 2008
USA's Consumer Reports warns pain pills can worsen headaches
8 September 2008
Albemarle hikes ibuprofen price
8 September 2008
Germany's AOK tenders for more drug discounts
18 August 2008
NicOx complete enrollment in Ph III OA trial
28 July 2008
Dr Reddy's to distribute Albemarle's ibuprofen
14 July 2008
217 drugs moved to OTC status in France
7 July 2008
US FDA approves BASF excipient Kollicoat
26 May 2008
NicOx swings to a loss in 1st-qtr p R&D costs
26 May 2008
Maryland OKs Medicaid reimbursement for ActiPatch
28 April 2008
NicOx initiates two ABPM naproxcinod trials
10 March 2008
SCOT trial to compare Celebrex' safety with that of older NSAIDs
24 December 2007
UPDATE: EMEA to withdraw lumiracoxib approval
24 December 2007
US FDA clears Watson's generic Combunox
3 December 2007
Albemarle to raise price of ibuprofen
27 September 2007
NSAIDs linked to risk of urinary retention
17 September 2007
Australia's TGA withdraws Novartis' coxib OA painkiller Prexige on liver safety fears
20 August 2007
Prexige patients avoid BP increase of NSAIDS
25 June 2007
UK's MHRA consults on P status naproxen
30 April 2007
Wyeth ends SCOLR license deal
19 March 2007
Horizon settles Ph III US HZT-501 trial design
15 January 2007
Horizon completes $21M financing to advance NSAIDs pipeline
15 January 2007
Indian Pharma cuts 886 drug prices
13 November 2006
FTC consents to Watson purchase of Andrx on conditions
6 November 2006
OVATION Pharma debuts NeoProfen
31 July 2006
New Indian drug price cuts of 10%-70%
26 June 2006
UK's MHRA acts on Tesco's Nurofen offer
24 April 2006
Study links Pfizer's painkiller Celebrex to an increased risk of myocardial infarction
13 March 2006
Indian pharmas protest US govt bids exclusion
16 January 2006
EU OKs Boots takeover by Reckit Benckiser
16 January 2006
Dihydrocodeine, codeine label change call in UK
22 August 2005
Poland and Russia boost Zentiva sales
15 August 2005
Perrigo gets FDA OK for Rx ibuprofen
25 July 2005
Glimmer of hope for Merck & Co's Vioxx
18 July 2005
Buyers line up for Boots' OTC business
20 June 2005
SCOLR secures contract maker of 24hr-ER PSE tablets
13 June 2005
Forest Labs' sales hit by Celexa competition
25 April 2005
SCOLR to develop three new CDT drugs
22 April 2005
Forest Labs debuts Combunox in USA
28 March 2005
SCOLR secures raloxifene-making contract
14 February 2005
SCLOR Pharma raises $15 million
14 February 2005
Novartis considers limited initial approval of Prexige in the USA
14 February 2005
More additions to Italy's Prontuario
10 January 2005
Business update by Bentley Pharma
1 November 2004
One in 10 children in UK at risk of undetected ADRs
4 October 2004
Spain's Farmasierra sees profits rising 20%
28 June 2004
Andrx debuts generic Vicoprofen
19 April 2004
Warning about aspirin-induced asthma
1 March 2004
US FDA to educate about OTC painkillers
2 February 2004
Ibuprofen carries "little risk of GI toxicity" as OTC analgesic
15 December 2003
Concern at Australian NSAID sales proposal
4 August 2003
Teva gets go-ahead for Vicoprofen generic
21 April 2003
Zimbabwe currency woes push up Rx prices
24 March 2003
Dr Reddy's first own-label brand in USA
13 January 2003
India raises antifungal, Parkinson's drug prices
5 August 2002
US insurers requiring prior OK for COX-2s
25 March 2002
Shasun of India moves focus into R&D
28 January 2002
Singapore to selectively allow some drugs for OTC sale.
21 January 2002
Net income up 33% at Forest Labs.
21 January 2002
UK MCA seeks GSL switch for eight drugs
5 July 2001
Brazil may withdraw dipirone products
21 June 2001
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
